‘Empathy counterbalancing’ to mitigate the ‘identified victim effect’? Ethical reflections on cognitive debiasing strategies to increase support for healthcare priority setting

Author:

Smids JillesORCID,Bomhof Charlotte H CORCID,Bunnik Eline MariaORCID

Abstract

Priority setting is inevitable to control expenditure on expensive medicines, but citizen support is often hampered by the workings of the ‘identified victim effect’, that is, the greater willingness to spend resources helping identified victims than helping statistical victims. In this paper we explore a possible cognitive debiasing strategy that is being employed in discussions on healthcare priority setting, which we call ‘empathy counterbalancing’ (EC). EC is the strategy of directing attention to, and eliciting empathy for, those who might be harmed as a result of one-sided empathy for the very ill who needs expensive treatment. We argue that governments have good reasons to attempt EC because the identified victim effect distorts priority setting in ways that undermine procedural fairness. We briefly outline three areas of application for EC and suggest some possible mechanisms that might explain how EC might work, if at all. We then discuss four potential ethical concerns with EC. First, EC might have the counterproductive effect of reducing overall citizen support for public funding of expensive medical treatments, thereby undermining solidarity. Second, EC may give rise to a ‘competition in suffering’, which may have unintended side effects for patients who feature in attempts at EC. Third, there may be doubts about whether EC is effective. Fourth, it may be objected that EC comes down to emotional manipulation, which governments should avoid. We conclude that insofar these concerns are valid they may be adequately addressed, and that EC seems a promising strategy that merits further investigation.

Funder

Koningin Wilhelmina Fonds Kankerbestrijding

Publisher

BMJ

Reference29 articles.

1. Ministry of Health, Welfare and Sport . Geneesmiddel Trodelvy Niet in Basispakket - Nieuwsbericht - Rijksoverheid.NL [Medicine Trodelvy not in the basic package]. Ministerie van Algemene Zaken 2023. Available: https://www.rijksoverheid.nl/actueel/nieuws/2023/03/28/geneesmiddel-trodelvy-niet-in-basispakket

2. Spetter E . RTL Nieuws. 2023 Kankermedicijn uitbehandelde patiënt niet vergoed: ‘Pijnlijk, maar middel te duur’ [Anticancer medicine not reimbursed: ’Painfull, but medicine too expensive’], . 2023 Available: https://www.rtlnieuws.nl/nieuws/nederland/artikel/5376232/ingerid-uitgezaaide-borstkanker-kankermedicijn-basispakket

3. Ministry of Health . Antwoorden op Kamervragen (VSO) over Kamerbrief Prijsonderhandelingen Trodelvy - Kamerstuk - Rijksoverheid.NL [Answers to Parliamentary Questions regarding the Letter to the Parliament Price Negotiations Trodelvy]. Ministerie van Algemene Zaken 2023. Available: https://www.rijksoverheid.nl/documenten/kamerstukken/2023/05/24/kamerbrief-verslag-schriftelijk-overleg-vso-n-a-v-kamerbrief-prijsonderhandelingen-trodelvy

4. Wat Vindt NRC | Goed dat er Een Grens Wordt Gesteld Aan Het Uitdijen Van Het Basispakket Van de Zorgverzekering [NRC’s opinion - Good that a limit is being set to the expansion of the basic health insurance package]. 2023. Available: https://www.nrc.nl/nieuws/2023/04/17/goed-dat-grens-wordt-gesteld-aan-uitdijen-basispakket-a4162219

5. Media influence on Herceptin subsidization in Australia: application of the rule of rescue?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3